United Community Center to expand dementia care services for Latinos
Congratulations UCC on the Community Impact grant!
Shaping a future free from Alzheimer's disease
Congratulations UCC on the Community Impact grant!
On June 7, the U.S. Food and Drug Administration (FDA) approved the drug aducanumab for the treatment of Alzheimer’s disease. Read a breakdown on what this means for people living with Alzheimer's disease and family caregivers.
Wisconsin Alzheimer's Institute (WAI) is excited to welcome Sarah Klein in her new role as WAI administrator.
The 7th annual Breaking The Silence event welcomed more than 200 attendees on April 15, meeting for the first time virtually.
The program was the sixth edition of the Addressing Systemic Racism education series, held Friday, November 20.
WAI Regional Milwaukee Office director's accomplishments are featured in new issue of Quarterly magazine
Andrea Gilmore-Bykovskyi, PhD, RN is an assistant professor in the University of Wisconsin–Madison School of Nursing. She is also a co-investigator and informatics lead in the Wisconsin ADRC Care Research Core, where she directs an interdisciplinary research program used on promoting effective, equitable care and research for those living with and at risk for Alzheimer’s …
Dr. Carlsson joined the Dementia Matters podcast for an interview November 5, 2020
In a discussion that covered the long legacy of discrimination against Black people in American science and its continued effects on people of color's health and quality of life, the fifth Addressing Systemic Racism webinar drew an audience of more than 250.
Documentary featuring WRAP participants and researchers will premiere in November.